peptides and prostate cancer Peptide-based vaccines against cancer - Prostatepeptide bioregulator GPRP-targeted radiopharmaceuticals hold high promise for staging, restaging, and treatment Peptides and Prostate Cancer: A Promising Frontier in Treatment and Research

Vitaprost peptide The intricate world of peptides is increasingly revealing its potential in the fight against prostate cancer.作者：W Tai·2011·被引用次数：110—Cellular uptake of the peptide–drug conjugate was significantly higher in prostate cancer cellscompared to the parent drug. Moreover, both the peptide–drug ... These small chains of amino acids, fundamental building blocks of proteins, are emerging as powerful tools for diagnosis, targeted therapy, and even prevention作者：P Khatiwada·2023—Peptides TA1 and AT1 are cytotoxic to prostate cancer cells. AR and AR-V7 are essential for the survival and growth of prostate cancer cells (Simental et al.. Research into peptides and prostate cancer is a rapidly evolving field, offering hope for improved patient outcomes and a deeper understanding of this prevalent disease.作者：L Mezzasoma·2021·被引用次数：17—It is known that the endogenous biomolecules and NatriureticPeptides(NPs), such as ANP and BNP, inhibit inflammasome activation in immune cells.

One of the most exciting areas of investigation is peptide-based tumor immunotherapy. This approach aims to transform prostate cancer from a "cold" tumor, which is less responsive to the immune system, into a "hot" one, more susceptible to immune attack. Peptides can be engineered to stimulate the body's own immune defenses, effectively training them to recognize and eliminate cancer cells. This strategy holds significant promise, as highlighted by ongoing research exploring how peptide-based vaccines against cancer can target specific tumor antigens.

Furthermore, peptides are being developed to directly target and destroy cancer cells with remarkable precision.Selection and identification of ligand peptides targeting a ... For instance, certain peptides have demonstrated the ability to selectively induce cell death in AR-positive prostate cancer cells by interfering with androgen receptor (AR) signaling, a critical pathway for prostate cancer growth.A novel peptide explicitly induces prostate cancer cell ... Researchers are also investigating peptides that can selectively and swiftly target prostate cancer cells without harming healthy tissue, thereby minimizing side effects and improving the overall quality of life for patients. This targeted approach is crucial for conditions like prostate cancer, where precision is paramount.

The therapeutic potential extends to various types of peptides. Marine peptides, for example, have shown multiple anticancer effects and are being explored for their efficacy against prostate cancer. Similarly, bacterial peptides, such as Chromopeptide A, could suppress the development and migration of human prostate cancer cells both *in vitro* and *in vivo*.

Beyond direct cell killing, peptides are also proving invaluable in drug delivery and imaging.作者：SMP Vadevoo·2023·被引用次数：186—Tumor-homing peptides have been used for guiding nanoparticles to cancer cellsthrough direct interactions between the peptides and receptors or ... Tumor-homing peptides can act as guides, directing nanoparticles and therapeutic agents directly to cancer cells. This enhances the cellular uptake of peptide–drug conjugates, leading to more effective treatment compared to using the drug alone作者：X Li·2025·被引用次数：4—Additionally,peptides can induce immunogenic cell death (ICD) in prostate cancer cellsthrough ferroptosis, pyroptosis, and autophagy .... This is particularly relevant for advanced or metastatic forms of prostate cancer, where getting drugs to the tumor site effectively is a significant challenge. For example, some peptides may lead to breakthroughs in fighting metastatic androgen-independent prostate cancer by enabling precise drug targetingUMB researchers have identified a set ofClass II-restricted, naturally processed, strongly immunogenic peptidesderived from PSA that promise an effective vaccine to prevent and treat prostate cancer. The inventors showed that patients with a chronic inflammatory prostate condition called granulomatous prostatitis had ....

The development of GPRP-targeted radiopharmaceuticals is another significant advancement, holding high promise for the staging, restaging, and treatment of GPRP-expressing cancer, primarily prostate cancer. These targeted agents can visualize and even treat cancer with unprecedented accuracy.KU Cancer Center Researcher Secures .4M Grant to ...

Research is also delving into the mechanisms by which peptides exert their effects. Some peptides can induce immunogenic cell death (ICD) in prostate cancer cells through processes like ferroptosis, pyroptosis, and autophagy. Others are being studied for their ability to disrupt crucial interactions, such as peptides disrupting TM4SF3 interaction with AR or AR-V7, which are essential for prostate cancer cell survival and growth. Studies have shown that specific peptides like Peptides TA1 and AT1 are cytotoxic to prostate cancer cells.

The field is also exploring peptide analogs in the therapy of prostate cancer, with some showing potent effects in eliminating a significant percentage of prostate cancer cells. The identification of Class II-restricted, naturally processed, strongly immunogenic peptides derived from prostate-specific antigen (PSA) is paving the way for novel immunotherapies. PSA peptides are being investigated as a potential treatment modality, with early research suggesting feasibility.

Moreover, peptides are being engineered to target specific genetic anomalies found in prostate tumors.New Peptide Helps Cancer Drugs Break Into Tumors For instance, researchers have identified a molecule that can selectively attack prostate tumors with a particular genetic mutation, leaving healthy cells unharmed. This offers a more personalized and less toxic approach to treatment.

The journey of peptides in oncology is ongoing.New Peptide Helps Cancer Drugs Break Into Tumors While much of the research is still in preclinical or early clinical stages, the breadth of applications – from immunotherapy and targeted cell death to drug delivery and molecular imaging – underscores their immense potential.Peptides as multifunctional players in cancer therapy As our understanding of peptides and prostate cancer deepens, these remarkable molecules are poised to play an increasingly vital role in improving the lives of countless individuals affected by this diseaseDevelopment of a Peptide–Drug Conjugate for Prostate .... The exploration of peptides for prostate health continues to be a critical area of medical research.